Add to ORKGBackground: CA 15-3 is the most widely used serum marker in breast cancer. Currently, its main uses are in the surveillance of patients with diagnosed disease and monitoring the treatment of patients with advanced disease. Methods: Preoperative CA 15-3 concentrations were measured prospectively in 600 patients with histologi-cally confirmed breast cancer. Marker concentrations were related to patient outcome by both univariate and multivariate analysis. Results: After a median follow-up of 6.27 years, patients with high preoperative concentrations of CA 15-3 (>30 units/L) had a significantly shorter overall survival pattern than those with low concentrations. As a prog-nostic factor, CA 15-3 was independent of tumor size
BACKGROUND: To investigate the association between tumor markers [cancer antigen 15-3 (CA 15-3) and ...
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis...
BACKGROUND: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA ...
Background: CA 15-3 is the most widely used serum marker in breast cancer. Currently, its main uses ...
Background: Breast cancer makes the major burden of carcinomas in females. Timely diagnosis and trea...
In this study of 500 patients with breast carcinoma, we have prospectively assessed the role of preo...
Abstract: Background: Cancer Antigen 15-3 (CA 15-3) is a tumor-associated antigen used as serum mark...
Background & Aims The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3...
Tumor response to first-line chemotherapy in advanced breast cancer offers prognostic information an...
To assess the prognostic value of presurgical CA15.3 in a large cohort of patients with early breast...
Estimation of CA15-3 at presentation of breast cancer is important as it is an independent prognosti...
Lakmini KB Mudduwa,1 Gaya B Wijayaratne,2 Harshini H Peiris,3 Shania N Gunasekera,1 Deepthika Abeysi...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
PURPOSE: Tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) are w...
BACKGROUND: Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC)...
BACKGROUND: To investigate the association between tumor markers [cancer antigen 15-3 (CA 15-3) and ...
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis...
BACKGROUND: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA ...
Background: CA 15-3 is the most widely used serum marker in breast cancer. Currently, its main uses ...
Background: Breast cancer makes the major burden of carcinomas in females. Timely diagnosis and trea...
In this study of 500 patients with breast carcinoma, we have prospectively assessed the role of preo...
Abstract: Background: Cancer Antigen 15-3 (CA 15-3) is a tumor-associated antigen used as serum mark...
Background & Aims The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3...
Tumor response to first-line chemotherapy in advanced breast cancer offers prognostic information an...
To assess the prognostic value of presurgical CA15.3 in a large cohort of patients with early breast...
Estimation of CA15-3 at presentation of breast cancer is important as it is an independent prognosti...
Lakmini KB Mudduwa,1 Gaya B Wijayaratne,2 Harshini H Peiris,3 Shania N Gunasekera,1 Deepthika Abeysi...
The utility of measuring carcinoembryonic antigen(CEA) and cancer antigen 15-3 (CA15-3) levels in pa...
PURPOSE: Tumor markers such as carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) are w...
BACKGROUND: Primary chemotherapy (PC) is used for down-staging locally advanced breast cancer (LABC)...
BACKGROUND: To investigate the association between tumor markers [cancer antigen 15-3 (CA 15-3) and ...
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis...
BACKGROUND: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA ...